|
|||
|
|
|||
|
 |
Important safety information | Prescribing Information | Glossary | |
 | |||
|
Insulin Pump InformationMore and more people with diabetes are switching from injecting insulin to using an insulin pump. This section is intended to answer some of the questions you may have about insulin pumps. Explore our insulin pump section to learn more about insulin pumps, decide if insulin pump therapy is right for you, get tips on traveling with an insulin pump and more.
Who should consider an insulin pump? People who might want to consider using an insulin pump:
Be sure to talk to your doctor or diabetes educator to find out if an insulin pump is right for you. Words that are hyperlinked are defined in the glossary section Should you consider an insulin pump? Learn about why insulin pumps are recommended and what responsibilities come with them on our insulin therapy page. References: 1. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care. 1996;19:324-237. 2. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care. 2002;25;593-598. | ||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||||||
 | |
|
NovoLog® [insulin aspart (rDNA origin) injection]Indication and Usage: NovoLogŪ is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus. Important Safety Information: NovoLogŪ is a fast-acting insulin. You should eat a meal within 5 to 10 minutes after using NovoLogŪ to avoid low blood sugar. Do not inject NovoLogŪ if you do not plan to eat right after using NovoLogŪ. Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLogŪ. Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin. Do not mix NovoLogŪ with any other insulins when used in a pump or with any insulins other than NPH when used with injections by syringe. Do not take NovoLogŪ if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLogŪ. If you take too much NovoLogŪ your blood sugar may fall too low. Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLogŪ dose may change if you take other medicines. The most common side effect of insulin therapy, including NovoLogŪ is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information. FlexPen® and NovoLog® are registered trademarks of Novo Nordisk A/S. Disclaimer | Privacy | Contact Us | Novonordisk-us.com
|
 | |
